|
|
Volumn 10, Issue 6, 2014, Pages 911-915
|
|
Immunotherapy for high-grade glioma
|
|
Author keywords
dendritic cell; glioblastoma; high grade glioma; immunotherapy; monoclonal antibody; vaccine therapy
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CD47 ANTIGEN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
DENDRITIC CELL VACCINE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 8;
FLUOROURACIL;
IMA 950;
INDOLEAMINE 2,3 DIOXYGENASE;
NIMOTUZUMAB;
PEPTIDE VACCINE;
RINDOPEPIMUT;
TEMOZOLOMIDE;
UNCLASSIFIED DRUG;
VOCIMAGENE AMIRETROREPVEC;
ANGIOGENESIS INHIBITOR;
CANCER VACCINE;
EPIDERMAL GROWTH FACTOR RECEPTOR VIII;
MONOCLONAL ANTIBODY;
SUBUNIT VACCINE;
CANCER IMMUNOTHERAPY;
CANCER PROGNOSIS;
CONFERENCE PAPER;
GENE TARGETING;
GENE THERAPY;
GLIOMA;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LEUKAPHERESIS;
MEDICAL SOCIETY;
MULTICENTER STUDY (TOPIC);
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
UNITED STATES;
ANTAGONISTS AND INHIBITORS;
BRAIN NEOPLASMS;
CANCER GRADING;
DENDRITIC CELL;
GENETICS;
IMMUNOLOGY;
IMMUNOTHERAPY;
PATHOLOGY;
PROGNOSIS;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
CANCER VACCINES;
CTLA-4 ANTIGEN;
DENDRITIC CELLS;
GENETIC THERAPY;
GLIOMA;
HUMANS;
IMMUNOTHERAPY;
NEOPLASM GRADING;
PROGNOSIS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
VACCINES, SUBUNIT;
|
|
EID: 84903141740
PISSN: 14796694
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/fon.14.20 Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (8)
|
